Public reporting burden for this collection of information is estimated to average 1 hour per response, including the time for reviewing instructions, searching existing data sources, gathering and maintaining the data needed, and completing and reviewing this collection of information. Send comments regarding this burden estimate or any other aspect of this collection of information, including suggestions for reducing this burden to Department of Defense, Washington Headquarters Services, Directorate for Information Operations and Reports (0704-0188), 1215 Jefferson Davis Highway, Suite 1204, Arlington, VA 22202-4302. Respondents should be aware that notwithstanding any other provision of law, no person shall be subject to any penalty for failing to comply with a collection of information if it does not display a currently valid OMB control number. PLEASE DO NOT RETURN YOUR FORM TO THE ABOVE ADDRESS.
INTRODUCTION:
Sulfur Mustard (HD): The sulfur mustard (bis-2-(chloroethyl) sulfide) could effectively be used to produce casualties in the battlefield and to force opposing troops to wear full protective equipment thereby slowing down the tempo of military operations. It could also be used with devastating results against civilian targets, and such use of HD by S. Hussein's military forces in Iraq has been well documented. The extensive and slow healing skin lesions following exposure to HD would also place a heavy burden on the medical services of military and public health organizations.
Effects of HD on human skin:
A characteristic of sulfur mustard exposure is the occurrence of a symptom free period of some hours post exposure. The duration of this period and the severity of the subsequent lesions are dependent upon the mode of exposure, the environmental temperature and individual to individual variations. In the first hour after exposure to mustard gas vapor or liquid no signs or symptoms are usually produced, but nausea, vomiting and eye smarting have been occasionally reported. Six to 24 hours post-exposure skin inflammation ensues followed by lesion formation and blistering.
Treatment of HD:
There is no antidote or effective treatment for mustard gas intoxication.
Mechanism of CEES/HD-induced skin damage:
Oxidative stress is an important mechanism for HD induced skin injury. HD and its analog 2-chloroethylethyl sulfide (CEES) induce alkylation of DNA, and rapid oxidation of intracellular proteins and lipids. CEES/HD are known also to react with the major intracellular antioxidant GSH; depleting it with a subsequent loss of protection against reactive oxygen species (ROS) and an activation of inflammatory responses. Considerable evidence suggests that HD toxicity is associated with an increased generation of damaging free radical production and promote apoptosis.
As detailed below, we have found that oxidative stress and pro-inflammatory cytokines play a key role in the toxicity of CEES. The PI's laboratory is part of a DOD funded group termed the "Advanced Medical Countermeasure Consortium". This group is systematically evaluating the overall hypothesis that oxidative stress, pro-inflammatory agents, and apoptotic cell signaling are the key factors in the toxicity of mustard gas. In recent years, there has been an enormous expansion of findings on the molecular mechanism of inflammatory responses and its relationship to oxidative stress [1] [2] [3] [4] .
We are currently taking advantage of this rich wealth of background information to help define the molecular links between inflammatory agents, oxidative stress and mustard gas toxicity. We have found that macrophages exposed to CEES have a decreased level of intracellular GSH, which is even further diminished in the presence of LPS [5, 6] . Pretreatment of the macrophages with N-acetyl cysteine (NAC) protects against the loss of intracellular GSH. NAC serves to promote the synthesis of GSH and, this is the likely mechanism for the protective effect of NAC against CEES/HD toxicity as reported by the PI's laboratory and other researchers.
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The HD-induced depletion of GSH together with protein and lipid oxidation has far reaching consequences that have not been previously appreciated. HD-induced pathophysiology may occur in large part due to a disruption of redox homeostasis. Redox homeostasis is dependent upon the balance between oxidants and antioxidants. Redox sensitive gene expression is determined by the redox status of the cell. Signal transduction events induced by endogenous stimuli alter the redox state of the cell. GSH depletion influences a variety of cellular signaling process, such as activation and phosphorylation of stress kinases (JNK, p38, PI-3K) via sensitive cysteine-rich domains; activation of sphingomyelinase ceramide pathway, and activation of AP-1 and NFkB, with subsequent gene transcription [7, 8] . GSH levels are inversely related to the activity of NFkB [9] . NFkB regulates many genes involved in inflammation such as: inducible nitric oxide sythase (iNOS), proinflammatory cytokines, Il-1, TNF-alpha, interleukin 6 (IL-6), chemokine, IL-8, E-selectin, vascular cell adhesion molecule 1 (ICAM-1), and granulocytemacrophage colony stimulating factor (GM-CSF) [8, 10] .
Arroyo et al. found a dose dependent increase in TNF-alpha, IL-6, IL1 beta in SM treated human keratinocyte cells [11] . Signal transduction has also been demonstrated for CEES, wherein TNF-alpha, sphingomyelinase levels, caspase 3, 8, and 9 were all elevated [12] . Stone et al. [5] have found that inflammatory cytokines exacerbate the toxicity of CEES, as well as LPS. GSH levels are rapidly depleted by TNF-alpha. It is postulated that oxidative stress induced by CEES is further amplified by the loss of GSH and inflammatory cytokine production, thus exacerbating CEES-induced pathophysiology.
Rationale for the use of Liposomal Antioxidants: One way of reversing or preventing the ROS-induced cellular injury is via topical application of antioxidants. Vitamin E (tocopherols and tocotrienols), GSH, N-acetylcysteine (NAC), and lipoic acid are very effective antioxidants. Their antioxidative potential and importance in skin pathophysiology had been tested previously in a large number of investigations [2, [13] [14] [15] [16] [17] . However, the delivery of antioxidants to skin remains problematic in some cases. The intact skin allows the passage of small lipophilic substances but, in most cases, efficiently retards the diffusion of water-soluble molecules.
Liposomes are phospholipid vesicles composed of lipid bilayers enclosing an aqueous compartment. Hydrophilic molecules can be encapsulated in the aqueous spaces and lipophilic molecules can be incorporated into the lipid bilayers. Liposomes are unique in their ability to simultaneously deliver both water-soluble (in their aqueous inner space) and lipid-soluble antioxidants (in the phospholipid bilayer) to cells and tissues. They represent an ideal drug delivery system that enhances penetration of the active ingredient into the skin, localizes the drug at the site of action, and reduces percutaneous absorption.
Stone et al. [18] have reviewed the use of antioxidant liposomes in the general area of free radical biology and medicine as well as the relevant application of this technology to weapons of mass destruction. The term "antioxidant liposome" is relatively new and refers to liposomes containing lipid soluble chemical antioxidants, water-soluble chemical antioxidants, enzymatic antioxidants, or combinations of these various antioxidants. Antioxidant liposomes hold great promise in the 6 treatment of many diseases and conditions in which oxidative stress plays a prominent role. Several studies have clearly indicated that the liposomal antioxidant formulations compared to that of the free non-encapsulated antioxidants exert a far superior protective effect against oxidative stress-induced tissue injuries.
Military Significance:
The overall objective of this study is to develop an effective prophylactic therapy against CEES-induced skin damage (analogous to HD effect) based on the topical application of antioxidant liposomes. Our preliminary data suggest that antioxidant liposomes are very effective in preventing CEES toxicity to stimulated macrophages. This study will determine potential effectiveness of various liposome formulations in ameliorating the CEESinduced skin injury. The successful outcome from this research will comprise a treatment that will reduce or prevent casualties in the battlefield thus preserving combat effectiveness. Furthermore, the timely administration of this treatment regimen will also avert the devastating results of CEES against civilians that might be exposed to CEES during a terrorist attack. In this investigation, we hope to optimize the combination of antioxidants in the liposomes to achieve the maximum therapeutic effect. In addition, we will address practical issues with regards to the large scale preparation and storage of antioxidant liposomes with long-term physical, chemical and pharmacological stability.
BODY:
Originally, we proposed using EpiDerm cultured human skin tissues as a working model to study CEES cytotoxicity and protective effects of antioxidant liposomes. However, EpiDerm tissues are expensive, and in order to save resources, we have chosen cultured normal human epidermal keratinocytes (NHEK) purchased from Cambrex to use in our first series of experiments. In addition, we have used cultured immortalized human keratinocytes CCD 1106 KERTr purchased from ATCC, which are easy to culture and allow unlimited number of passages, whereas NHEK spontaneously transform after 5-7 passages (a major and costly limitation). These issues were discussed and recommended by USAMRICD scientist Dr. R. Ray who specializing in studies of HD toxicity mechanisms. We plan to collect the bulk of preliminary results with CEES (cell viability, apoptosis, cytokine release, oxidative stress parameters) and to optimize antioxidant liposome formulations using cultured human keratinocytes, and then perform final experiments with the EpiDerm tissues. As discussed below, this strategy has proven useful since we have already optimized the technique for delivering maximally toxic levels of CEES to cultured skin cells by use of dimethyl sulfoxide (DMSO).
Task 1:
In these initial experiments we will characterize the toxicity of CEES to the keratinocytes or EpiDerm model as a function of CEES dose and exposure time. We will also determine: (1) how apoptosis contributes to CEES induced toxicity by measuring both capase-3 activity and DNA fragmentation; (2) if immuno-stimulators (LPS, PMA) and pro-inflammatory cytokines (TNF-α, IL-1β) increase CEES toxicity to human keratinocytes/EpiDerm tissues.
It is postulated that apoptosis is the major cell death mechanism at low doses of CEES or HD whereas necrosis is the dominant mechanism at higher concentrations of CEES or HD and longtime exposures. We further anticipate that immuno-stimulators such as pro-inflammatory cytokines, LPS and PMA will enhance CEES toxicity to human keratinocytes. Task 2: Similar to HD, CEES induces oxidative stress in the skin cells resulting in ROS generation, DNA damaging, protein and lipid oxidation, depletion of intracellular glutathione and vitamin E (in particular, α-tocopherol and γ-tocopherol). We will determine the influence of CEES on various oxidative stress parameters using cultured human keratinocytes and, later, the EpiDerm model. Particular emphasis will be placed on intracellular ROS monitoring, GSH/GSSG ratio, tocopherol depletion/tocopheryl quinone formation, and protein oxidation.
Task 3:
We will examine the pharmacokinetics of the antioxidant liposomes following their topical application to the human keratinocytes or EpiDerm tissues. Human skin cells will be treated with antioxidant liposomes containing both water-and lipid-soluble antioxidants (bifunctional liposomes), and the antioxidant status (protein oxidation, GSH/GSSG ratio, tocopherol/tocopheryl quinone ratio) of the tissues will be measured as a function of dose and treatment time. The water-soluble antioxidants to be used are GSH, NAC and α-lipoic acid (ALA); the lipid-soluble antioxidants to be used are α-tocopherol and γ-tocopherol. We will optimize the liposome formulations in order to achieve optimal enrichment of the cells with the antioxidants.
Task 4:
We anticipate that liposome-encapsulated antioxidants will be more effective than free non-encapsulated antioxidants in preventing CEES toxicity in human skin cells. We will test the effectiveness of topical application of the optimal antioxidant liposome formulations (which will be determined in Task 3) against the CEES-induced skin damage. Cultured human keratinocytes and EpiDerm system will be utilized to reveal most protective antioxidant liposome formulations.
Task 5:
We will explore the possibility of manufacturing antioxidant liposomes in large scale industrial quantities. We will further optimize antioxidant liposome formulations in order to enhance their long-term physical, chemical and therapeutic stability. The most protective antioxidant liposomes (which will be determined in Task 4) will be further characterized for the physical and chemical stability as a function of storage time and conditions. Optimal storage conditions will be found out. The liposome therapeutic effectiveness will be also monitored during long-term storage under various conditions.
Progress during fist year:
Work on this grant was substantially delayed due to issues related to the hiring of key research personnel. The PI had initiated the process of hiring a highly qualified postdoctoral researcher, Dr. Victor Paromov, in June 2005 in order to have him ready to begin work on this project at the start date. However, due to the long process of transferring of his visa status to ETSU by US 8 CIS, Dr. Paromov was able to start only in November 2005, effectively delaying work for more then 4 months.
Liposome stability, cost and FDA Considerations
As mentioned in the Introduction, liposomes are unique in their ability to effectively deliver both water-and lipid-soluble antioxidants to the skin cells. As liposomes are artificially made vehicles, the question of their long-term stability especially under non-optimal conditions (high temperature, dry air) is of high importance. It would not be appropriate to use unstable liposome formulations for the Task 3 and Task 4, which are of greatest importance in this project. Therefore, we addressed the question of the liposome stability at the beginning of our studies.
Relevant to Task 5, we have obtained the instrumentation required to prepare antioxidant liposomes in large quantities and characterize their particle size distribution. To be able to manufacture large unilamellar antioxidant liposomes in quantities up to 10-20 L per day, we have optimized a micro-fluidizing technique. Using M-110L Laboratory Microfluidizer® Processor we can produce liposomes at a rate of 270 ml/min at 18,000 PSI. This device was chosen since this technique can be scaled-up to industrial levels without changing liposomes properties/characteristics, which is important for future FDA considerations. A long range consideration in the formulation of antioxidant liposomes is the very high cost of highly purified phosphatidyl choline used to make antioxidant liposomes. Purified phosphatidyl choline (i.e., dipalmitoyl phosphatidyl choline) is very useful for our initial in vitro testing but would be too expensive for a commercial product useful to the DOD. The PI has, therefore, initiated conversations with the American Lecithin Co. (www.americanlecithin.com ) which has extensive experience and expertise in the use of soybean phosphatidyl choline to make liposomes. This company has supplied us with 100 g samples of various soybean phospholipids for testing. Currently we have used PL 85 G phosphatidyl choline, phospholipon 90G and phospholipon 90H (fully hydrogenated) for testing in our antioxidant liposome formulations. These products possess a high quality at lower cost (than synthetic phospholipids) and relevant FDA files are on record.
In our preliminary results, we have found that alpha-tocopherol containing liposomes were effective in protecting macrophages from CEES induced cytotoxicity. α-Tocopherol is the primary form of vitamin E found in plasma and is the primary lipid soluble antioxidant in blood. We have found, however, that γ-tocopherol is taken up by cells in culture to higher extent then α-tocopherol [19] . In the experiment plan in this proposal we will test liposomes made with either α-tocopherol or γ-tocopherol or mixtures of both. γ-Tocopherol is also very expensive and a commercial antioxidant-liposome formulation based on this vitamin E isoform would be prohibitively expensive. The PI has, therefore, also made contact with commercial suppliers of mixed tocopherols with high a content of γ-tocopherol. The DSM Nutritional Products (www.dsm.com ) has supplied us with 100 g quantities of mixed tocopherols (with a very high content of γ-tocopherol) for testing in the antioxidant liposomes.
The liposome formulations have been characterized by measuring: 1) particle size distribution using a dynamic light scattering Model 380 Nicomp particle analyzer; (2) liposome antioxidant (e.g., vitamin E) content composition and stability; and (3) potential liposome cytotoxicity in human skin cells using the MTT assay (see Task 1 ). In addition, liposomes containing encapsulated water-soluble antioxidants, such as glutathione (GSH) and N-acetyl cysteine (NAC), were tested on their chemical stability (GSH oxidation) and physical stability (GSH leakiness).
The following large unilamellar liposomal (LUV) formulations were made: (1) blank liposomes (no water or lipid soluble antioxidants); (2) GSHliposomes (75 mM GSH); (3) Toc-liposomes; (4) 2x-Toc-liposomes; (5) T/G liposomes (3.33 mM α-tocopherol with 75 mM GSH). These liposomes have been further divided into groups: (1) stored at room temperature or in refrigerator at 4°C; (2) stored with or without EDTA or urate as chelating agent. Table 1 shows the composition of the alpha-tocopherol liposomes. Particle size distribution: Our results with respect to size distribution are still in the process of being analyzed. To date we can tentatively conclude that: (1) typical liposome preparation mostly contains vesicles with sizes distributed within 100-300 nm interval; (2) three passes through the homogenizer produces slightly smaller but more uniform liposomes (Figure 1) , further increase of the number of passes does not does not improve the vesicle size distribution; (3) encapsulation of a water-soluble antioxidant, such as NAC or GSH does not significantly alter the liposome size distribution; (4) addition of a lipophilic antioxidant, such as α-tocopherol, in the liposome formulation slightly changes average particle size (Figure 2) , with high levels increasing and medium levels not having much of an effect. Figure 2 . Vitamin E influences liposome size distribution. Blank liposomes contain no antioxidants; Mid. Vitamin E (VE) liposomes contain 6.67% mol./mol. α-tocopherol); High VE liposomes contain 13.33% mol./mol. α-tocopherol. The liposomes were prepared using a M-110L Laboratory Microfluidizer® Processor; vesicle size distribution analyzed using the Model 380 Nicomp particle size analyzer.
Antioxidant content composition and stability: We have analyzed changes in lipid composition of vitamin E containing liposomes during prolonged storage. Table 2 shows the changes in vitamin E content of α-or γ-tocopherol containing liposomes during 4 week storage either at room temperature (RT) or at 4° C. Tocopherols were determined within the liposome samples using HPLC with electrochemical detection. Vitamin E containing liposomes stored at RT were completely depleted of vitamin E. In addition, phase separation was also visually registered during the 4 th week of storage at RT. Liposomes stored at 4° C maintained their physical stability and average particle size, however lost up to 60% of their vitamin E content due to oxidation. There were no significant differences in long-term stability between liposomes containing α-tocopherol or γ-tocopherol. We are now looking at the influence of phospholipid composition, particularly the polyunsaturated fatty acid content of the lipids to determine their influence on tocopherol stability. GSH-Liposome leakiness during pro-longed storage. 1 mL of "G-liposomes" or "G/T-liposomes" were put in sterile dialysis bag (8 kDa cut off) and dialyzed twice against 50 mL PBS. Dialyzed liposome samples were put in fresh PBS and incubated continuously at RT or at 4 C (fridge). GSH concentration within the each liposome sample and in the buffer was measured during 4 week incubation. Liposome leakiness was expressed as a percent of GSH in the buffer from the total GSH of each liposome sample. GT-lipos, 4C
GSH Leakage from Liposomes during Prolongrd Storage
Also we analyzed the leakiness of glutathione (GSH), a water-soluble encapsulated antioxidant, during prolonged storage (see Figure 3) . In this experiment, GSH was encapsulated within the liposomes, and the external, non-encapsulated GSH removed by exhaustive dialysis. The liposomes were then stored either at RT or at 4° C, and GSH concentration in the buffer monitored using Tietze's method [20] . GSH leakage from the liposomes to the buffer is a measure of liposomal membrane stability as GSH molecules (charged) cannot penetrate through an intact lipid bilayer.
Our results show that the liposomes maintained high physical stability within at least 1 month of storage. Only 3% of the GSH content was lost from the GSH or G/T-containing liposomes. The loss of small amount of GSH from liposomes might be explained by the fact that the vesicles are not uniform. Although most of the vesicles have sizes within 100-200 nm intervals, actual size of some particles may differ significantly. Vesicles with variable sizes can fuse and divide spontaneously loosing their encapsulated content. However, as it is clear from Figure 3 such perturbations are relatively minor.
In addition we analyzed chemical stability of the water-soluble content (GSH) encapsulated within the liposomes. Figure 4 shows the loss of GSH due to oxidation to form GSSG (in GSH equivalents) as a function of storage time for the GSH-liposomes and the GSH/α-Tocopherol (G/T-) containing liposomes at RT or 4° C. These data show that GSH is oxidized fairly rapidly at room temperature compared to 4° C. Moreover, the presence of α-tocopherol does not retard GSH oxidation. In addition, G/Tliposomes, similar to α-tocopherol containing liposomes, loose their physical stability (visible phase separation) during the 4 th week of storage at RT. . GSH oxidation (conversion to GSSG) within liposome fraction during pro-longed storage. "G-liposomes" or "G/T liposomes" were stored at room temperature (RT) or at 4 C. GSH and GSSG concentrations within the liposome samples was measured after 3, 5, 7, 14, 21 and 28 days of storage. Oxidation of GSH content of the liposomes was expressed as a percent of GSH converted to GSSG relatively to the total GSH/GSSG content of each sample. 
GSH Oxidation in Liposomes during

GT-lipos, 4C
The experiments describe above were done in the absence of a metal ion chelator. Chelators act as antioxidants by minimizing oxidation catalyzed by iron ions (a contaminant in all buffers). We have, therefore, analyzed the influence of metal ion chelators (EDTA and urate) on GSH chemical stability within the liposomes. Figure 5 and Figure 6 show the effect of the chelators on GSH oxidation within the G-or G/T-liposomes. Neither urate nor EDTA protected the GSH content of the liposomes during storage at 4° C. However, both chelators slightly protected the GSH of G/T-liposomes but not that of the G-liposomes stored at RT (Figure 7) . Based upon the above studies we concludes that antioxidant liposomes posses a high degree of physical stability even at RT. We found that the loss of anti-oxidative potency of the liposomes due to the chemical oxidation of the antioxidants is a major difficulty during longterm storage. We anticipate that NAC and alpha lipoic acid (ALA) would be more stable than GSH. Clearly, the storage temperature is emerging as a key factor in long term stability. Both lipid-and water-soluble antioxidant contents are being preserved much better at 4° C. These data suggest that GSH and/or vitamin E containing liposomes would have to be either used relatively soon after being formulated (perhaps within a week) if stored at RT or could be stored at 4° C for up to 4 weeks. Chelator effect on GSH oxidation (conversion to GSSG) within liposome fraction during pro-longed storage. "G/T-liposomes" were stored at 4C (fridge). GSH and GSSG concentrations in the liposome samples was measured after 2, 6, 14, and 35 days of storage. Oxidation of GSH content of the liposomes was expressed as a percent of GSH converted to GSSG relatively to the total GSH/GSSG content of each liposome sample.
Chelator Effect on GSH Oxidation in Liposomes during Prolonged Storage at T = 4 C (G/T-liposomes)
Cytotoxic Effect of CEES On Cultured Human Keratinocytes
Task 1: We have investigated cytotoxic effect of CEES on cultured human keratinocytes. . Chelator effect on GSH oxidation (conversion to GSSG) within liposome fraction during 2-week storage. "G-liposomes" or "G/T-liposomes" were stored at RT or 4 C (fridge). GSH and GSSG concentrations in the liposome samples was measured after 14 days of storage. Oxidation of GSH content of the liposomes was expressed as a percent of GSH converted to GSSG relatively to the total GSH/GSSG content of each liposome sample. These results sufficiently differ with our previous results obtained with murine macrophages simultaneously exposed to CEES and LPS [5] . 14 which in turn produce a feed-back reaction in keratinocytes stimulating apoptosis [10, 11, 14, 21 ].
Chelator effect on GSH oxidation in liposomes during
CEES Cytotoxic Effect on NHEK Cells
In the experiments described above we have applied CEES in ethanol. According to the USAMRICD studies, human skin exposed to 300 µM concentration of HD will demonstrate oxidative stress, cytokine release, and massive apoptosis followed by necrosis. As a less toxic analog of HD, CEES would be expected to produce similar changes in keratinocytes at concentrations 3-4 times higher, i.e., 1 mM [22].
We, however, did not observe substantial cell death in human keratinocytes exposed to fairly high levels of CEES applied as a stock solution in ethanol. This method of CEES application appeared to result in a phase separation of the CEES from the cell culture medium thereby decreasing its effective concentration. We have discussed this difficulty with USAMRICD specialist Dr. R. Ray at the Bioscience Review 2006 Conference. Dr. R. Ray has recommended two alternative methods of CEES application. The first method requires directly adding CEES to a plastic tube with the culture medium followed by extensive vortexing and immediately applying this mixture to cells in a multi-well plate. The second method requires preparation of a CEES stock solution in dimethyl sulfoxide (DMSO) which is then added to cells in a multi-well plate with gentle mixing. DMSO is known to be an very effective vehicle for a delivery of organic compounds to skin and enhances HD toxicity.
We have tried both these alternative methods of CEES application and the results as shown in Figure 8 (see above). Figure 9 shows the dose-response at lower levels of CEES. CEES directly mixed with medium and applied to the keratinocytes showed moderate toxicity. In marked contrast, CEES in DMSO was much more toxic. We will, therefore, optimize CEES/DMSO method of application in our next series of experiments looking at the potential protective effect of antioxidant liposomes (Tasks 3 and 4). Pre-treatment of cells with DMSO alone for 2 hours did not potentiate the toxicity of CEES (in medium) suggesting that DMSO is only acting to improve the solubility of CEEES.
In addition to the above described studies we will monitor cytokine release (particularly IL-8 and TNF-α) as they have been found to be superior markers for CEES induced inflammation. Similarly, markers of apoptosis (caspase 3 and DNA fragmentation) will be measured in future experiments. 
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CEES/DMSO Toxicity in CCD 1106 KERTr Cells
Oxidative Stress Parameters in CEES Treated Human Keratinocytes
Task 2: We have done a few preliminary experiments to monitor oxidative stress parameters in CEES (ethanol) treated human keratinocytes. Figure 10 shows the generation of intracellular superoxide anion (O2*) in NHEK cells during 4 hours of incubation with 10 mM CEES. Superoxide levels were measured using a specific fluorescent dye, dihydroethidium (HEt). Intracellular oxidation of HEt (measured as fluorescence of the product) reflects superoxide generation in cytoplasm. NHEK cells were loaded with 10 µM HEt for 1 hour, washed, and exposed to CEES. As was expected, 10 mM CEES induced high levels of superoxide production in NHEK cells. Interestingly, the production superoxide anion in NHEK cells appears to increase in a similar manner as CEES induced toxicity. These data confirm that oxidative stress, and ROS generation in particular, is an important factor in CEES induced cell death.
CEES toxicity and ROS generation in NHEK cells
We also measured intracellular production of hydrogen peroxide (H2O2) in CEES/ethanol treated NHEK cells (Figure 11) . The decreased oxidation of DCFH at higher CEES levels can be potentially explained by the fact that this dye is also sensitive to intracellular NO. Previously, we have found that CEES inhibits NO production in murine macrophages [6] . It is possible that a similar effect occurred in the human keratinocytes. Additional experiments to measure NO production in keratinocytes will be needed to explore this possibility.
Task 3:
Measurements of α-tocopherol and GSH uptake by human keratinocytes after incubation with antioxidant liposomes are currently in progress.
Task 4:
We have initiated experiments with four different types of antioxidant liposomes in order to test their protective abilities against CEES toxicity. Figure 12 shows an effect of NAC/T-liposomes (see description on page 9) while NHEK cells were incubated for 24 hours with 10 mM CEES applied as a stock solution in ethanol. Interestingly, NAC/T-liposomes were not only protective, but also stimulated proliferation of NHEK cells both in the presence and in the absence of CEES. Blank liposomes (vesicles of similar size distribution composed only with phospholipids and cholesterol, but not containing antioxidants) did not show any protective effect, as was expected. Figure 13 illustrates the influence of Blank liposomes, G-liposomes, G/T-liposomes, or Tliposomes on NHEK cell growth inhibition after either 24 or 48 hour of incubation with 10 mM CEES/ethanol. The highest cytotoxic effect of CEES (71% of control viability) was detected after 48 hours of incubation with CEES. After 48 hours blank-liposomes were not protective against CEES (67%) and decreased cell viability to 69% without CEES; GSH containing liposomes were also not protective against CEES (71%) and decreased cell viability to 71% without CEES; alpha-tocopherol containing liposomes were also not protective against CEES (72%) and decreased cell viability to 88% without CEES; only liposomes containing both GSH and alphatocopherol were protective against CEES (87%) and, surprisingly, increased cell proliferation without CEES to 113%. Interestingly, antioxidant liposomes not only show protective effect against CEES-induced cell damage in keratinocytes, but also stimulate the cell growth and proliferation. These experiments are need to be repeated using DMSO as a vehicle for CEES in order to achieve its maximum cytotoxic effect in human keratinocytes, allowing us to test antioxidant liposomes under the most stringent conditions. We will also be measure cytokine release (TNF-α, IL-8, IL-6) and apoptosis indices (caspase 3, DNA fragmentation) monitoring as additional biomarkers of CEES/DMSO induced cell damage. 
NAC/T-Liposomes Protect NHEK Cells against CEES
CONCLUSION:
Based upon the results described above, we conclude that antioxidant liposomes posses a high degree of physical stability even at RT. We found that the loss of anti-oxidative potency of the liposomes due to the chemical oxidation of the antioxidants is the major difficulty during longterm storage. We anticipate that NAC and ALA would be more stable than GSH. Clearly, storage temperature has emerged as a key factor in long term stability. Both lipid-and watersoluble antioxidant contents are preserved much better at 4° C. These data suggest that GSH and/or vitamin E containing liposomes would have to be either used relatively soon after being formulated (perhaps within a week) or could be stored at 4° C for up to 4 weeks.
Experiments further demonstrating CEES induced oxidative stress in human keratinocytes have been initiated. CEES induces generation of superoxide radicals and the increase in CEES toxicity has a pattern that parallels the intracellular accumulation of superoxide. Influence of immunostimulators (LPS, PMA) and pro-inflammatory cytokines (TNF-α, IL-1β) on CEES toxicity (in ethanol) to human keratinocytes has been tested. In these initial experiments, none of the immuno-stimulators enhanced CEES toxicity as measured by the MTT assay. Measurement of other oxidative stress parameters (protein oxidation, GSH depletion), and monitoring of apoptotic markers (caspase 3, DNA fragmentation) and pro-inflammatory cytokines (TNF-α, IL-8, IL-6) are currently in progress.
NAC/α-tocopherol containing liposomes showed significant protective effect against CEES (in ethanol) induced skin cell damage in our preliminary experiments. GSH/α-tocopherol containing liposomes also showed some protective effect. However, these experiments needed to be repeated using DMSO as a vehicle for CEES in order to achieve its maximum damaging effect in human keratinocytes allow us to test antioxidant liposomes under the most toxic conditions.
